Avmax, Inc.
Records under this name other than patents Avmax, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Avmax, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,180,666 | Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds Formerly held Term ended Term ended Mar 5, 2019 · From the USPTO record | Term ended | Term ended Mar 5, 2019 | From the USPTO record |
| US 6,121,234 | Use of essential oils to increase bioavailability of orally administered pharmaceutical compounds Formerly held Lapsed on the fee record Ended Sep 19, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 19, 2012 | From the USPTO record |
| US 6,372,756 | Epimorphian compound and its use Lapsed on the fee record Ended Apr 16, 2006 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2006 | From the USPTO record |
| US 5,665,386 | Use of essential oils to increase bioavailability of oral pharmaceutical compounds Formerly held Term ended Term ended no later than Sep 9, 2017 · Low confidence | Term ended | Term ended no later than Sep 9, 2017 | Low confidence |
| US 5,716,928 | Use of essential oils to increase bioavailability of oral pharmaceutical compounds Formerly held Term ended Term ended no later than Feb 10, 2018 · Low confidence | Term ended | Term ended no later than Feb 10, 2018 | Low confidence |
| US 5,916,566 | Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds Formerly held Term ended Term ended no later than Jun 29, 2019 · Low confidence | Term ended | Term ended no later than Jun 29, 2019 | Low confidence |
| US 5,962,522 | Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds Formerly held Term ended Term ended no later than Oct 5, 2019 · Low confidence | Term ended | Term ended no later than Oct 5, 2019 | Low confidence |